Drug intelligence / Profile preview

avocado-soybean unsaponifiables

Development stage
Phase 4
Lead developer
Laboratoire Expanscience
Modality
Small Molecules
Administration
Oral
01

Overview

Avocado-soybean unsaponifiables is a natural vegetable extract composed of the unsaponifiable fractions of avocado and soybean oils, typically in a 1:2 ratio. It is used primarily as a symptomatic slow-acting drug in osteoarthritis (SYSADOA) for hip and knee osteoarthritis, but also considered for scleroderma, menopause-related symptoms, and other conditions[1][3][5][8]. ASU is chondroprotective, anti-inflammatory, anabolic, and anticatabolic—stimulating collagen and proteoglycan synthesis, decreasing matrix metalloproteinase activity, reducing pro-inflammatory cytokine production (such as IL-1, IL-6, TNF-alpha), and blocking COX-2 expression and PGE2 secretion. Its principal active components include phytosterols (beta-sitosterol, campesterol, stigmasterol), isoflavones, tocopherols, and squalene[1][3]. Its mechanism of action is not fully understood but is thought to act by modulating connective tissue metabolism and reducing inflammatory mediators in articular joints[1][3][8].

Brand names
Piascledine
Other names
avocado/soybean unsaponifiablesavocado soy unsaponifiablesavocado/soy unsaponifiablesArthrocen
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS2 (Nitric Oxide Synthase 2)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)MMP12 (Macrophage Metalloelastase)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on avocado-soybean unsaponifiables.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avocado-soybean unsaponifiables.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call